HELX

Technical Sentiment Analysis for Franklin Genomic Advancements ETF (HELX). As of 2026-02-12, Franklin Genomic Advancements ETF (HELX) is exhibiting a Sell technical sentiment. Our proprietary analysis, which aggregates 14 technical signals, shows that 6 indicators are flashing buy, while 8 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status. Currently, the Relative Strength Index (RSI) for HELX stands at 32.74, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.62, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 9.54 and the Commodity Channel Index (CCI) at -137.39 further confirm a -2.47 outlook for the ETF.

Support, Resistance & Moving Averages. From a structural perspective, HELX is trading above its 60-day moving average of $36.76 and above its 200-day long-term moving average of $31.67. Key price levels to watch include the immediate resistance at $36.7 and strong support at $34.26. A break above $36.7 could signal a bull continuation, while falling below $34.26 may test the next Fibonacci floor at $33.09.